Ocelot Bio
San Diego, US · Founded 2020 · Delaware corporation · 4 known investors
Find your way into Ocelot Bio
Founders & leadership
GH
Geoffrey HarrisExecutive
Board
CS
JN
Investors · 4
Funding
SEC filings, press & company announcements$75M disclosed across 3 rounds · 2021–2023
- $36Mseries AMar 2022 · 2 sourcesSource ↗
▶$3MraisedJul 2023 · 5 investors · PharmaceuticalsRule 506(b)
▶$3MraisedJul 2023 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Camille SamuelsDirector
- Donald SantelDirector
- Jack NielsenDirector
- Katherine StultzExecutive Officer, Director
- Jennifer SchranzDirector
- Offering amount
- $12M
- Amount sold
- $3M
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$36MraisedApr 2021 · 5 investors · PharmaceuticalsRule 506(b)
▶$36MraisedApr 2021 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Camille SamuelsDirector
- Jack NielsenDirector
- Geoffrey HarrisExecutive Officer, Director
- Offering amount
- $38M
- Amount sold
- $36M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Ocelot Bio's investors?
- Ocelot Bio's investors include RA Capital, Venrock, Venrock Associates, Vivo Capital.
- How much funding has Ocelot Bio raised?
- Ocelot Bio has disclosed $75M raised across 3 rounds.
- Where is Ocelot Bio headquartered?
- Ocelot Bio is headquartered in San Diego, US.